Phase 1 Trial: The COSMYC Trial, ZEN-3694 Combination With BAT
/0 Comments/in Clinical Trial, Metastatic, Phase 2/by MaxPhase 2 Trial Enrolling: Combination Therapy for Metastatic Castration-Resistant Prostate Cancer
/0 Comments/in Clinical Trial, Metastatic, Phase 2/by MaxPhase 1 Enrolling: Sylvester Cancer Center Launches Innovative Clinical Trial for High-Grade Neuroendocrine Tumors
/0 Comments/in Clinical Trial, Metastatic, Phase 1/by MaxUpdate: FC705 Signals a Leap Forward in Prostate Cancer Therapy, Outperforming Pluvicto
/0 Comments/in Clinical Trial, Metastatic, Phase 2/by MaxPhase 1 Results: Personalized Cancer Vaccine PGV001 Shows Promise Across Multiple Cancer Types
/0 Comments/in Clinical Trial, Not PCa related/by MaxIDOV-Immune A Viral Therapy Turning the Tide Against Cancer
/0 Comments/in Clinical Trial, Metastatic, Phase 1/by MaxPhase 1 for TTX-MC138: Breakthrough RNA Therapeutic Advances in Targeting Metastatic Cancers
/0 Comments/in Clinical Trial, Metastatic, Phase 1/by MaxUPDATE On ENV105: Safety Lead-In Completed for This Innovative Therapy
/0 Comments/in Clinical Trial, Metastatic, Phase 2/by MaxFOR46: New Experimental Therapy Shows Tumor Shrinkage in Advanced Prostate Cancer Patients
/0 Comments/in Clinical Trial, Metastatic, Phase 1/by MaxProject Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
225Ac abiraterone acetate ADC ADT AI ai in healthcare antibody-drug conjugate apalutamide ASCO 2025 ATM bispecific antibody bone metastases bone metastasis BRCA cancer immunotherapy castration-resistant prostate cancer CDK12 clinical trial clinical trials crispr CYP11A1 inhibitor darolutamide drug repurposing drug resistance enzalutamide HRR immune checkpoint inhibitors immunotherapy mcrpc metastatic castration-resistant prostate cancer metastatic hormone-sensitive prostate cancer mHSPC mRNA nanotechnology olaparib oncolytic virus personalized medicine prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data T-cell therapy theranostics
Latest Posts
- Newsletter 23/2025 June 8, 2025
- Protein Design Leaps Forward Thanks to AI June 5, 2025
- Phase 1 Trial of XL309: USP1 Inhibitor Targeting DNA Repair in Solid Tumors June 5, 2025
- UPDATE About ACE-232: Phase 1 Trial of a Novel CYP11A1 Inhibitor for mCRPC June 5, 2025